Volume 17, Number 8—August 2011
Research
Asymptomatic Primary Merkel Cell Polyomavirus Infection among Adults
Table 2
Signs and symptoms at seroconversion study visit or during previous 6 months for MCV seroconverters and controls matched by study visit among participants in the Multicenter AIDS Cohort Study, Pittsburgh, Pennsylvania, USA*
Signs or symptom |
Seroconverters |
Controls |
p value |
|||
No. evaluated |
No. (%) with sign or symptom |
No. evaluated |
No. (%) with sign or symptom |
|||
Shortness of breath >2 weeks | 31 | 1 (3.2) | 75 | 8 (10.7) | 0.28 | |
Shortness of breath at time of visit | 28 | 1 (3.6) | 73 | 6 (8.2) | 0.67 | |
Cough >2 weeks | 31 | 1 (3.2) | 75 | 4 (5.3) | 1 | |
Cough now | 31 | 0 | 75 | 3 (4.0) | 0.55 | |
Sore throat >2 weeks | 31 | 1 (3.2) | 75 | 5 (6.7) | 0.67 | |
Sore throat now | 31 | 1 (3.2) | 75 | 2 (2.7) | 0.50 | |
Rash >2 weeks | 31 | 2 (6.5) | 75 | 4 (5.3) | 1 | |
Rash now | 31 | 3 (9.7) | 75 | 4 (5.3) | 0.41 | |
Bruising >2 weeks | 31 | 0 | 75 | 4 (5.3) | 0.32 | |
Bruising now | 31 | 0 | 75 | 3 (4.0) | 0.55 | |
Fatigue >2 weeks | 31 | 0 | 75 | 5 (6.7) | 0.32 | |
Fatigue now | 31 | 1 (3.2) | 75 | 4 (5.3) | 1 | |
Weight loss >10 pounds | 31 | 0 | 75 | 1 (1. 3) | 1 | |
Weight loss now | 31 | 0 | 75 | 0 | NA | |
Diarrhea >2 weeks | 31 | 2 (6.5) | 75 | 0 | 0.08 | |
Diarrhea now | 31 | 1 (3.2) | 75 | 0 | 0.29 | |
Fever >2 weeks | 31 | 0 | 75 | 0 | N/A | |
Fever now | 31 | 0 | 75 | 0 | N/A | |
Lymphadenopathy >2 weeks | 31 | 3 (9.7) | 75 | 5 (6.7) | 0.69 | |
Lymphadenopathy now | 31 | 3 (9.7) | 75 | 5 (6.7) | 0.69 | |
Night sweats >2 weeks | 31 | 0 | 75 | 4 (5.3) | 0.32 | |
Night sweats now | 31 | 0 | 75 | 2 (2.7) | 1.0 | |
Headache >2 weeks | 31 | 1 (3.2) | 75 | 3 (4.0) | 1.0 | |
Headache now | 31 | 1 (3.2) | 75 | 2 (2.7) | 1.0 |
*MCV, Merkel cell polyomavirus; NA, not applicable.
1These authors contributed equally to this article.